Subject: Lexaria Corp. (LXRP) to Build a 2nd. World Class Marijuana Grow Facility
View this email online if it doesn't display correctly
Lexaria Announces a 2nd. Larger World Class Medical Marijuana Production Facility
(Ticker LXRP) to be built in Eastern Ontario 
Regulated Marijuana Production
Lexaria (LXRP) has made a radical shift of business, preparing to deploy its skills and resources in the most productive way possible, for the benefit of all stakeholders. It's not a decision we took lightly: all government regulated medications and substances are of great importance and deserve prudent risk managing best business practices. With nearly a decade of business operations and regulatory compliance in both the USA and Canada, serving a number of different securities, banking, and auditing regimes, Lexaria will add transparency and procedural control to every aspect of the marijuana industry that we are involved in.
Our first step into the market is a Joint Venture signed March 5, 2014 with Enertopia Corp. Enertopia is one of Canada's leading medical marijuana companies with two recent acquisitions recently announced. Enertopia has the capability of putting more than 60,000 sq ft of production space into use in the cultivation of medical marijuana, through its partly owned subsidiaries.
Our Joint Venture gives Enertopia the ability to share projects and opportunities with Lexaria Corp, a Right-Of-First-Refusal that catapults Lexaria above the ranks of many also-ran competitors. And the Joint Venture allows for the two companies to work together, if we both choose, on bigger projects that might be out of the reach of either company. Together, we are much stronger than the sum of our parts!
Lexaria (LXRP) has developed a business plan wherein we will try to acquire more than one license to produce marijuana in Canada under the MMPR legislation. We are also evaluating potential legal grow locations in those jurisdictions in the USA where they are permitted, because it is our intention to be a North American producer of legal marijuana.
Most states require some amount of vertical integration with regards to the marijuana industry. We embrace this as it is our intention, over time, to become a vertically integrated international marijuana company; always of course with the caveat of acting within the regulatory environment of the time and places in which we operate. One day we hope to have a research and science facility to optimize strains; to grow our own inventory; to build our own brand recognition; and to be part of all the steps right to the consumer's door.
"The Medical Marijuana Business just might be one of the most Recession-Proof Industry Sectors there are."
There is no boom and bust cycle that is apparent. The average demographic age in North America continues to increase, with over 44 million people in the USA today at the age of 65 or over. Age-related illnesses will continue to grow, and some fraction of these people looking for an alternative to opiate-based painkillers have a real need for pain-relief choices.
BREAKING NEWS RELEASE!
Lexaria Announces Second Production Facility and Vendor Intention to Finance up to 3,000,000
May 27, 2014 (Al Bawaba Business via COMTEX) -- Kelowna, British Columbia--(Newsfile Corp. - May 27, 2014) - Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it has entered a detailed Letter of Intent with Huntington Property Group Inc, an Ottawa-based real estate developer for its second marijuana production facility in Canada. As provided for in Letter of Intent, Lexaria also announces a financing intention of up to 3,000,000, including Vendor Financing, subject to certain terms and conditions as detailed in the Letter of Intent.
The facility is located in the Eastern Ontario area and is of a total potential area of over 80,000 sq ft; to be completed in an expected multi-phase development program. The first phase is to be over 20,000 sq ft. Lexaria will be the operator of this facility and would own 100% rights, with no overrides or royalties due to any party. Lexaria is issuing no shares whatsoever in order to acquire the rights to this facility.
No lease (rent) payments are scheduled to begin until such time as the municipality grants its approval of the building zoning for marijuana production purposes. Lexaria and the building owner are preparing an application to the municipality for such approval and based upon available information anticipate that such approval could be granted within 90 days. In the event the municipality does not for any reason approve the building for the purpose of medical marijuana production, Lexaria and the building owner have agreed to locate and use an alternate building.
Alan Whitten, President of Huntington Property Group Inc. says, "We are happy to get involved in this burgeoning sector. We believe in Lexaria's growth plan and have confidence in their personnel to achieve their plans, and are pleased to commit to it. We look forward to a mutually beneficial long term relationship, as our investment indicates."
Lexaria notes that this agreement for its second production facility was negotiated and entered only six weeks after its first production facility was announced, which was the 49%-owned joint venture with Enertopia Corp.
Lexaria will own 100% interest in the production facility by paying 100% of all initial and ongoing expenses related to the project. An initial 10-year lease will be entered, with options to renew the lease for an additional 16 years. The vendor is contributing up to 1,000,000 in cash payments directed toward the conversion costs required to renovate for the marijuana production facility, thus reducing Lexaria's capex in the renovation costs.
Lexaria is also pleased to announce that a number of investors, including the building owner, have agreed in principle and subject to suitability and other conditions, to invest up to 2,000,000 into Lexaria, on terms in accordance with Canadian Securities Exchange and all regulatory requirements including required restricted periods. The intended investment would be part of the financing recently announced by Lexaria, and would be by Canadian accredited, non-US persons. Proceeds from this financing will be used to build out the Eastern Ontario facility for the purposes of medical marijuana production, and for general working capital. Lexaria cautions that the Letter of Intent is a preliminary step only and cannot provide any assurances that the Letter of Intent will result in a successfully closed acquisition or financing.
The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Chris Bunka commented that "We are very pleased to enter the next phase of our growth initiative with the prestigious Huntington Property Group Inc. We intend to nurture this relationship for the benefit of all our shareholders. We share a common vision, and will also enjoy long term benefits as confirmed by their capital commitment."
Lexaria believes that all stakeholders, including prospective customers, shareholders and others, are best served by Lexaria operating under more than a single Health Canada license under the MMPR. Multiple licenses protect shareholders and customers by adding redundancy to operations, and avoiding or mitigating loss in the event of unexpected production complications or any other unpredictable events.
Lexaria is now involved in two potential marijuana production facilities, both located in Ontario, each capable of significant expansion from Phase I initial buildout, and each large enough to offer significant cost efficiencies compared to smaller facilities.
The new facility in no way reduces Lexaria's commitment to its previously announced greater Toronto area facility, which continues to advance separately. The Company looks forward to reporting additional developments on the advancement of this facility as they occur.
Exciting times are ahead for LXRP investors as the Company GROWS!
Grow with LXRP in a Medical Business that is Considered Recession Proof!
Lexaria Corp. (LXRP-OTCQB)
http://www.lexariaenergy.com
To Subscribe to our newsletter: http://stockpumper.com/
Please read our disclaimer at: StockPumper.com
http://stockpumper.com/review-disclaimer.php
Disclaimer – Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment adviser or licensed stockbroker before investing. You should not invest or trade in any penny stock unless are you are fully prepared, willing, able and expect to lose a hundred pct of your funds,including any profiled company or other company in any other manner mentioned or alluded to by StockPumper as defined in any medium whatsoever. Compensation: three thousand dollars for a one day awareness on LXRP from a third party. The service is provided as a guide to some available investments only, which must be tempered by the investment experience and independent decision making process of the subscriber. The accuracy of issuer documents and information that is submitted to and, its affiliated members and its management for inclusion on this site is principally the responsibility of the particular issuer and its management, its affiliated members and its management is neither responsible for, nor undertakes any steps to check, the accuracy of any information provided by featured companies to potential investors. You should confirm to your own satisfaction the veracity of any information prior to entering into any investment.